| Symbol | TLRY |
|---|---|
| Name | TILRAY BRANDS, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Medicinal Chemicals and Botanical Products |
| Address | 265 TALBOT STREET WEST, LEAMINGTON, N8H 4H3, United States |
| Telephone | +1 844 - 845-7291 |
| Fax | — |
| — | |
| Website | https://www.tilray.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001731348 |
| Description | Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products through Manitoba Harvest and beer through SweetWater. Additional info from NASDAQ: |
Tilray Medical Welcomes Progress in Germany’s Medical Cannabis Framework and Supports Continued Policy Development
Read moreTilray Medical begrüßt die positiven Entwicklungen im deutschen Rechtsrahmen für medizinisches Cannabis und setzt sich für dessen kontinuierliche Weiterentwicklung ein
Read moreMontauk Brewing Company Expands Its Coastal Footprint with New North Shore Brewpub
Read moreTilray Medical Accelerates the Commercial Expansion of Tilray Medical-Branded Cannabis Medicines in the UK with First Direct-to-Patient Launch Through Lyphe Clinic and Lyphe Dispensary
Read moreHi*Ball® Energy Powers into the English Football League with Wolverhampton Wanderers Partnership
Read moreGendel Mitchell 🟢 acquired 2.5K shares of Tilray Brands, Inc. (TLRY) at $4.43 Transaction Date: Aug 06, 2026 | Filing ID: 005348
Read moreNew Form S-8 - Tilray Brands, Inc. <b>Filed:</b> 2026-07-31 <b>AccNo:</b> 0001140361-26-030508 <b>Size:</b> 238 KB
Read more